SAN ANTONIO & LANGENHAGEN, Germany--(BUSINESS WIRE)--Feb. 23, 2006--OncoVista, Inc. ("OncoVista") has acquired a controlling interest in AdnaGen AG ("AdnaGen"), based in Langenhagen, Germany. AdnaGen has developed and is marketing novel tests for the early detection and analysis of circulating tumor cells (CTCs). AdnaGen is currently marketing tests in Europe for breast and colon cancer. Efforts are underway to obtain U.S. F.D.A. approval to market these tests in the U.S.
